A Win For Miragen Therapeutics, Inc.
Mon 27 Jan 20 at 05:30 PM
Miragen Therapeutics, Inc. (MGEN:NASDAQ) jumped higher at $1.46, a gain of 50.5%. On Fri 24 Jan 20, MGEN:NASDAQ touched a New 2-Week High of $0.97. The stock got featured on our News Catalysts scanner on Thu 23 Jan 20 at 09:35 AM in the 'BIOTECH' category. From Fri 03 Jan 20, the stock recorded 57.14% Up Days and 60.00% Green Days
The stock spiked on Fri 24 Jan 20 at $1.4 with a volume of 21M+.
About Miragen Therapeutics, Inc. (MGEN:NASDAQ)
Miragen Therapeutics Inc is a clinical-stage biopharmaceutical company which engaged in discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics.
Top 10 Gainers:
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 210.61%
- Lianluo Smart Limited (LLIT:NASDAQ), 152.29%
- NanoViricides, Inc. (NNVC:NYSEMKT), 86.98%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 82.45%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 65.42%
- Miragen Therapeutics, Inc. (MGEN:NASDAQ), 50.52%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 50%
- Vaxart, Inc. (VXRT:NASDAQ), 30%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 28.33%
- Sophiris Bio, Inc. (SPHS:NASDAQ), 27.23%